Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia.
about
PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat.Kinetically Selective Inhibitors of Histone Deacetylase 2 (HDAC2) as Cognition EnhancersGenomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.Disruption to schizophrenia-associated gene Fez1 in the hippocampus of HDAC11 knockout mice.Isoform-selective histone deacetylase inhibitors: the trend and promise of disease treatment.Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine-based Histone Deacetylase Inhibitors.
P2860
Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Therapeutic potential of isofo ...... he treatment of schizophrenia.
@en
type
label
Therapeutic potential of isofo ...... he treatment of schizophrenia.
@en
prefLabel
Therapeutic potential of isofo ...... he treatment of schizophrenia.
@en
P2093
P2860
P356
P1476
Therapeutic potential of isofo ...... he treatment of schizophrenia.
@en
P2093
Edward B Holson
Florence F Wagner
Michael C Lewis
Michel Weïwer
P2860
P304
P356
10.4155/FMC.13.141
P577
2013-09-01T00:00:00Z